Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup

Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup. Scientific Reports 2022. 12, 12460. doi: 10.1038/s41598-022-16455-1